Lobbyists for doctors, hospitals and drug companies are urging lawmakers to derail a planned government panel that health industry officials fear will sharply curb Medicare spending — a critical revenue source for them, I wrote in a story published in Politico and Kaiser Health News.
The American Medical Association, the American Hospital Association and Pharmaceutical Research and Manufacturers of America are among many groups that want to weaken or kill the Independent Payment Advisory Board, which was created by the health law to cap the growth of Medicare spending beginning in 2015.
